# Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial

> **NCT00617201** · PHASE2 · COMPLETED · sponsor: **Sharon Walsh** · enrollment: 50 (actual)

## Conditions studied

- Substance Abuse

## Interventions

- **DRUG:** atomoxetine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00617201
- **Lead sponsor:** Sharon Walsh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-08-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00617201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00617201, "Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00617201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*